0.3165
Nexgel Inc stock is traded at $0.3165, with a volume of 93,088.
It is down -6.75% in the last 24 hours and down -24.82% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.3394
Open:
$0.339
24h Volume:
93,088
Relative Volume:
0.31
Market Cap:
$3.09M
Revenue:
$11.26M
Net Income/Loss:
$-3.09M
P/E Ratio:
-0.7895
EPS:
-0.4009
Net Cash Flow:
$-1.49M
1W Performance:
-10.09%
1M Performance:
-24.82%
6M Performance:
-69.57%
1Y Performance:
-85.81%
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NXGL
Nexgel Inc
|
0.3165 | 3.78M | 11.26M | -3.09M | -1.49M | -0.4009 |
|
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nexgel Inc Stock (NXGL) Latest News
NEXGEL (NXGL) terminates CEO and launches broad strategic review - Stock Titan
NEXGEL Names Brian Kieser Interim CEO, Launches Strategic Review - citybiz
symbol__ Stock Quote Price and Forecast - CNN
Nexgel, Inc. Forms Special Committee to Oversee Comprehensive Strategic Review and Value Creation - marketscreener.com
NEXGEL Appoints Brian Kieser To Replace CEO Adam Levy Effective August 21 - TradingView
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE - GlobeNewswire
NexGel Files to Register 15.25 Million Shares From Note Conversions - marketscreener.com
NexGel (NXGL) Earnings Report: The EPS Result Is Below Expectation in the Latest Session; Post-Earnings: Shares Move 5.05% Up in the Latest ReadingEarnings Call Transcript - dars.gov.et
NXGL | NexGel, Inc Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
NexGel (NXGL) Results at a Glance: The Bottom-Line Figure Trails Its Comparison in the Available Record; Share Response: Shares Finish 5.05% Up in Latest TradingEarnings Season Outlook - dars.gov.et
NexGel (NXGL) Earnings Brief: EPS Does Not Reach the Reported Estimate at the Close; Session Reaction - vinanet.vn
NexGel (NXGLW) Session Check: Records a 33.33% Increase to $0.02 in the Latest Reading; Level Check: the Session Ends Within the Reported Technical Boundaries in the Latest SessionCumulative Volume - vinanet.vn
Nexgel earnings missed by $0.30, revenue topped estimates - Investing.com Canada
Dow Falls 150 Points; NY Empire State Manufacturing Index Rises In August - Sahm
Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition - TipRanks
NexGel Q2 FY26 gross profit falls 11.84% to $1.11 million; revenue rises 27.8% to $3.69 million - Bitget
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp - Yahoo Finance
NexGel Q2 Loss Widens Sharply on $2.2M Interest and Derivative Charges - Minichart
Form 8K Nexgel Inc For: 17 August By Investing.com - Investing.com Nigeria
NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continue - TradingView
NEXGEL Q2 2026: Revenue $3.69M, Net Loss $2.87M as Company Transitions Post-Acquisition - TradingView
NEXGEL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
NEXGEL Reports Second Quarter 2026 Financial Results - The Manila Times
NEXGEL's Surgical Business Has a $795,000 Backlog—What's Holding It Up? - Stock Titan
NXGL Q2'26 Earnings: EPS estimate is (0.12) USD - TradingView
NEXGEL, INC. Q2 2026: Revenue $3.69M, EPS $(0.40) — 10-Q Summary - TradingView
NexGel (NXGL) pushes back Q2 report, cites audit review - Stock Titan
NexGel (NXGL) issues going‑concern warning after Q2 loss - Stock Titan
NexGel (NXGL) plans big share authorization boost and reverse split to protect Nasdaq listing - Stock Titan
NEXGEL, Inc. (NASDAQ:NXGL): Are Analysts Optimistic? - simplywall.st
NexGel Inc (NXGL) Dips 3.95% to $0.36, Testing Key Support ZoneCalendar Spread Trade - Vinanet
Nexgel Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
NexGel Inc (NXGL) Surges 15% as Micro-Cap Healthcare Stock Approaches Key ResistanceSupply Zone - dars.gov.et
NexGel shareholders constrain structural changes at annual meeting - The Globe and Mail
NexGel, Inc Revenue Breakdown – BOATS:NXGLW - TradingView
NXGL Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares LowerSegment Revenue Breakdown - vinanet.vn
NXGL Q1 2026 Earnings: EPS Loss Widens Sharply Beyond Estimates; Stock DeclinesFinancial Data - dars.gov.et
NexGel Updates CEO Employment Terms and Incentive Plan - The Globe and Mail
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Misses Estimates as Losses WidenEBITDA Analysis - dars.gov.et
Form 4 Nexgel Inc For: 29 July By Investing.com - Investing.com Canada
NexGel Inc (NXGL) Holds Near Key Support After Marginal DeclineLow Vol ETF - vinanet.vn
NexGel, Inc Revenue Breakdown – NASDAQ:NXGL - tradingview.com
NXGL|Nexgel Inc|Price:0.436|Chg%:-0.003 - TradingKey
Nexgel Inc (NXGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nexgel Inc (NXGL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nexgel Inc (NXGL) Balance Sheet - TradingKey
Nexgel Inc (NXGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nexgel Inc (NXGL) Cash Flow - TradingKey
NexGel, Inc Revenue Breakdown – NASDAQ:NXGLW - TradingView
Nexgel Inc (NXGL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexgel Inc Stock (NXGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer |
Jun 23 '26 |
Sale |
0.59 |
5,000 |
2,967 |
322,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 11 '26 |
Sale |
0.61 |
3,000 |
1,841 |
333,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 04 '26 |
Sale |
0.59 |
3,000 |
1,781 |
339,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 08 '26 |
Sale |
0.55 |
3,000 |
1,641 |
336,692 |
| Levy Adam R. | Chief Executive Officer |
Jun 01 '26 |
Sale |
0.59 |
2,000 |
1,172 |
342,692 |
| Levy Adam R. | Chief Executive Officer |
May 28 '26 |
Sale |
0.61 |
7,000 |
4,241 |
347,692 |
| Levy Adam R. | Chief Executive Officer |
May 29 '26 |
Sale |
0.60 |
3,000 |
1,801 |
344,692 |
| Levy Adam R. | Chief Executive Officer |
May 27 '26 |
Sale |
0.60 |
3,000 |
1,792 |
354,692 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):